NIAMS Clinical Trial Implementation Cooperative Agreement
Agency: National Institutes of Health
- 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research
Forecasted opportunityLast Updated: Jun 10, 2026
Important dates
- Forecasted post date: November 2, 2026
- Forecasted application due date: July 2, 2027
- Forecasted award date: April 3, 2028
- Forecasted project start date: April 3, 2028
- Fiscal Year: 2028
Award details
- Expected project funding: Not specified
- Expected awards: 4
Award min.
$250,000
Award max.
Not specified
- Funding opportunity number:PAR-28-031
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: June 10, 2026
- Archive date: Not specified
- Version: 1
Summary
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Clinical Trial Cooperative Agreement Program within the mission areas of the institute. This Notice of Funding Opportunity (NOFO) solicits cooperative agreement applications for implementation of investigator-initiated, single or multi-site, interventional clinical trials (all trial phases). Investigators who have completed all necessary preparation (e.g., the trial design, protocol synopsis, data analysis plan, etc.) through other means may apply for a NIAMS Cooperative Agreement Clinical Trial. The first phase is designed to allow the investigators to prepare the final aspects needed to start the trial, (e.g., establishing the single IRB (sIRB), contracts and reliance agreements with sites, hiring of staff, etc.). Transition to the second phase to begin the trial is dependent upon completion of the phase 1 milestones proposed by the investigator and approved by NIAMS. Phase 1 projects that meet their milestones will be administratively considered by NIAMS and prioritized for transition to the second phase. NIAMS expects trials to be hypothesis-driven and have the potential for high clinical impact within the research mission of NIAMS.
Eligibility
Miscellaneous
- Other
Government
- State governments
- County governments
- Public and Indian housing authorities
- City or township governments
- Special district governments
- Federally recognized Native American tribal governments
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Business
- For-profit organizations other than small businesses
- Small businesses
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: NIAMS_NOFOs@mail.nih.gov
NIAMS_NOFOs@mail.nih.gov
Link to additional information
No additional information is available
